Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Harland Sather
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Procedures
Concepts & Ideas
Chemicals & Drugs
Phenomena
Anatomy
Sign-in to see full Profile
Network (preview)
69
Gaynon, Paul
46
Steinherz, Peter
37
Nachman, James
35
Uckun, Fatih
34
Trigg, Michael
34
Heerema, Nyla
29
Sensel, Martha
28
Reaman, Gregory
23
Bleyer, Archie
20
Hutchinson, Raymond
20
Bostrom, Bruce
17
Lange, Beverly
14
La, Mei
13
Tubergen, DG
10
Reaman, Gregory
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Harland Sather (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Nachman James B; La Mei K; Hunger Stephen P; Heerema Nyla A; Gaynon Paul S; Hastings Caroline; Mattano Leonard A; Sather Harland; Devidas Meenakshi; Freyer David R; Steinherz Peter G; Seibel Nita L
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5189-94.
-
2009: Schultz Kirk R; Bowman W Paul; Aledo Alexander; Slayton William B; Sather Harland; Devidas Meenakshi; Wang Chenguang; Davies Stella M; Gaynon Paul S; Trigg Michael; Rutledge Robert; Burden Laura; Jorstad Dean; Carroll Andrew; Heerema Nyla A; Winick Naomi; Borowitz Michael J; Hunger Stephen P; Carroll William L; Camitta Bruce
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5175-81.
-
2008: Bhojwani Deepa; Kang Huining; Menezes Renee X; Yang Wenjian; Sather Harland; Moskowitz Naomi P; Min Dong-Joon; Potter Jeffrey W; Harvey Richard; Hunger Stephen P; Seibel Nita; Raetz Elizabeth A; Pieters Rob; Horstmann Martin A; Relling Mary V; den Boer Monique L; Willman Cheryl L; Carroll William L;
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(27):4376-84.
-
2008: French Deborah; Hamilton Leo H; Mattano Leonard A; Sather Harland N; Devidas Meenakshi; Nachman James B; Relling Mary V;
A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2008;111(9):4496-9.
-
2008: Seibel Nita L; Steinherz Peter G; Sather Harland N; Nachman James B; Delaat Cynthia; Ettinger Lawrence J; Freyer David R; Mattano Leonard A; Hastings Caroline A; Rubin Charles M; Bertolone Kathy; Franklin Janet L; Heerema Nyla A; Mitchell Torrey L; Pyesmany Allan F; La Mei K; Edens Cheryl; Gaynon Paul S
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2008;111(5):2548-55.
-
2007: Malempati Suman; Gaynon Paul S; Sather Harland; La Mei K; Stork Linda C;
Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5800-7.
-
2007: Nachman James B; Heerema Nyla A; Sather Harland; Camitta Bruce; Forestier Erik; Harrison Christine J; Dastugue Nicole; Schrappe Martin; Pui Ching-Hon; Basso Giuseppe; Silverman Lewis B; Janka-Schaub Gritta E
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.
Blood 2007;110(4):1112-5.
-
2007: Butturini Anna M; Dorey Frederick J; Lange Beverly J; Henry David W; Gaynon Paul S; Fu Cecilia; Franklin Janet; Siegel Stuart E; Seibel Nita L; Rogers Paul C; Sather Harland; Trigg Michael; Bleyer W Archie; Carroll William L
Obesity and outcome in pediatric acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2063-9.
-
2007: Satwani Prakash; Sather Harland; Ozkaynak Fevzi; Heerema Nyla A; Schultz Kirk R; Sanders Jean; Kersey John; Davenport Virginia; Trigg Michael; Cairo Mitchell S
Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(2):218-27.
-
2007: Schultz Kirk R; Pullen D Jeanette; Sather Harland N; Shuster Jonathan J; Devidas Meenakshi; Borowitz Michael J; Carroll Andrew J; Heerema Nyla A; Rubnitz Jeffrey E; Loh Mignon L; Raetz Elizabeth A; Winick Naomi J; Hunger Stephen P; Carroll William L; Gaynon Paul S; Camitta Bruce M
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Blood 2007;109(3):926-35.
-
2006: Nathan Paul C; Whitcomb Trish; Wolters Pamela L; Steinberg Seth M; Balis Frank M; Brouwers Pim; Hunsberger Sally; Feusner James; Sather Harland; Miser James; Odom Lorrie F; Poplack David; Reaman Gregory; Bleyer W Archie
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P.
Leukemia & lymphoma 2006;47(12):2488-504.
-
2006: Matloub Yousif; Lindemulder Susan; Gaynon Paul S; Sather Harland; La Mei; Broxson Emmett; Yanofsky Rochelle; Hutchinson Raymond; Heerema Nyla A; Nachman James; Blake Marilyn; Wells Linda M; Sorrell April D; Masterson Margaret; Kelleher John F; Stork Linda C;
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
Blood 2006;108(4):1165-73.
-
2006: Hilden Joanne M; Dinndorf Patricia A; Meerbaum Sharon O; Sather Harland; Villaluna Doojduen; Heerema Nyla A; McGlennen Ron; Smith Franklin O; Woods William G; Salzer Wanda L; Johnstone Helen S; Dreyer Zoann; Reaman Gregory H;
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
Blood 2006;108(2):441-51.
-
2005: Whitlock James A; Sather Harland N; Gaynon Paul; Robison Leslie L; Wells Robert J; Trigg Michael; Heerema Nyla A; Bhatia Smita
Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 2005;106(13):4043-9.
-
2005: Hunger Stephen P; Winick Naomi J; Sather Harland N; Carroll William L
Therapy of low-risk subsets of childhood acute lymphoblastic leukemia: when do we say enough?
Pediatric blood & cancer 2005;45(7):876-80.
-
2005: Tolar Jakub; Bostrom Bruce C; La Mei K; Sather Harland N
Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
Pediatric blood & cancer 2005;45(1):5-9.
-
2005: Olson Douglas P; Taylor Barbara J; La Mei; Sather Harland; Reaman Gregory H; Ivy S Percy
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group.
Leukemia & lymphoma 2005;46(5):681-91.
-
2005: Sutcliffe M J; Shuster J J; Sather H N; Camitta B M; Pullen J; Schultz K R; Borowitz M J; Gaynon P S; Carroll A J; Heerema N A
High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):734-40.
-
2005: Bassal Mylène; La Mei K; Whitlock James A; Sather Harland N; Heerema Nyla A; Gaynon Paul S; Stork Linda C
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Pediatric blood & cancer 2005;44(1):21-8.
-
2004: Heerema N A; Nachman J B; Sather H N; La M K; Hutchinson R; Lange B J; Bostrom B; Steinherz P G; Gaynon P S; Uckun F M;
Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(5):939-47.
-
2004: Panosyan Eduard H; Seibel Nita L; Martin-Aragon Sagrario; Gaynon Paul S; Avramis Ioannis A; Sather Harland; Franklin Janet; Nachman James; Ettinger Lawrence J; La Mei; Steinherz Peter; Cohen Lewis J; Siegel Stuart E; Avramis Vassilios I;
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2004;26(4):217-26.
-
2004: Heerema N A; Harbott J; Galimberti S; Camitta B M; Gaynon P S; Janka-Schaub G; Kamps W; Basso G; Pui C-H; Schrappe M; Auclerc M-F; Carroll A J; Conter V; Harrison C J; Pullen J; Raimondi S C; Richards S; Riehm H; Sather H N; Shuster J J; Silverman L B; Valsecchi M G; Aricò M;
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):693-702.
-
2004: Perentesis J P; Bhatia S; Boyle E; Shao Y; Shu X Ou; Steinbuch M; Sather H N; Gaynon P; Kiffmeyer W; Envall-Fox J; Robison L L
RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):685-92.
-
2003: Levy Adam S; Sather Harland N; Steinherz Peter G; Sowers Rebecca; La Mei; Moscow Jeffrey A; Gaynon Paul S; Uckun Fatih M; Bertino Joseph R; Gorlick Richard;
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2003;25(9):688-95.
-
2003: Kees U R; Heerema N A; Kumar R; Watt P M; Baker D L; La M K; Uckun F M; Sather H N
Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(5):887-93.
-
2003: Hutchinson Raymond J; Gaynon Paul S; Sather Harland; Bertolone Salvatore J; Cooper Herbert A; Tannous Raymond; Wells Linda M; Heerema Nyla A; Sailer Scott; Trigg Michael E;
Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1790-7.
-
2003: Bostrom Bruce C; Sensel Martha R; Sather Harland N; Gaynon Paul S; La Mei K; Johnston Katherine; Erdmann Gary R; Gold Stuart; Heerema Nyla A; Hutchinson Raymond J; Provisor Arthur J; Trigg Michael E;
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 2003;101(10):3809-17.
-
2003: Heath John A; Steinherz Peter G; Altman Arnold; Sather Harland; Jhanwar Suresh; Halpern Steven; Pieters Richard; Shah Narayan; Steinherz Laurel; Tannous Raymond; Terry William; Trigg Michael E;
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1612-7.
-
2002: Bhatia Smita; Sather Harland N; Heerema Nyla A; Trigg Michael E; Gaynon Paul S; Robison Leslie L
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.
Blood 2002;100(6):1957-64.
-
2002: Bhatia Smita; Sather Harland N; Pabustan Olga B; Trigg Michael E; Gaynon Paul S; Robison Leslie L
Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
Blood 2002;99(12):4257-64.
-
2002: Avramis Vassilios I; Sencer Susan; Periclou Antonia P; Sather Harland; Bostrom Bruce C; Cohen Lewis J; Ettinger Alice G; Ettinger Lawrence J; Franklin Janet; Gaynon Paul S; Hilden Joanne M; Lange Beverly; Majlessipour Fataneh; Mathew Pracad; Needle Michael; Neglia Joseph; Reaman Gregory; Holcenberg John S; Stork Linda
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 2002;99(6):1986-94.
-
2002: Heerema Nyla A; Sather Harland N; Sensel Martha G; La Mei K L; Hutchinson Raymond J; Nachman James B; Reaman Gregory H; Lange Beverly J; Steinherz Peter G; Bostrom Bruce C; Gaynon Paul S; Uckun Fatih M
Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia.
Cancer 2002;94(4):1102-10.
-
2002: Lange Beverly J; Bostrom Bruce C; Cherlow Joel M; Sensel Martha G; La Mei K L; Rackoff Wayne; Heerema Nyla A; Wimmer Robert S; Trigg Michael E; Sather Harland N;
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 2002;99(3):825-33.
-
2001: Uckun F M; Pallisgaard N; Hokland P; Navara C; Narla R; Gaynon P S; Sather H; Heerema N
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
Leukemia & lymphoma 2001;42(1-2):41-56.
-
2001: Gaynon P S; Bostrom B C; Hutchinson R J; Lange B J; Nachman J B; Steinherz P G; Sensel M G; Lee M K; Stram D O; Sather H N
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1916-25.
-
2001: Carter T L; Watt P M; Kumar R; Burton P R; Reaman G H; Sather H N; Baker D L; Kees U R
Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse.
Blood 2001;97(2):572-4.
-
2000: Gaynon P S; Trigg M E; Heerema N A; Sensel M G; Sather H N; Hammond G D; Bleyer W A
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2223-33.
-
2000: Heerema N A; Sather H N; Sensel M G; Lee M K; Hutchinson R J; Nachman J B; Reaman G H; Lange B J; Steinherz P G; Bostrom B C; Gaynon P S; Uckun F M
Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3837-44.
-
2000: Mattano L A; Sather H N; Trigg M E; Nachman J B
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(18):3262-72.
-
2000: Uckun F M; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman G H; Gaynon P S
Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3123-30.
-
2000: Heerema N A; Sather H N; Sensel M G; Zhang T; Hutchinson R J; Nachman J B; Lange B J; Steinherz P G; Bostrom B C; Reaman G H; Gaynon P S; Uckun F M
Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1876-87.
-
2000: Heerema N A; Sather H N; Sensel M G; Lee M K; Hutchinson R; Nachman J B; Lange B J; Steinherz P G; Bostrom B; Gaynon P S; Uckun F M
Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Cancer 2000;88(8):1945-54.
-
2000: Heerema N A; Sather H N; Sensel M G; Lee M K; Hutchinson R; Lange B J; Bostrom B C; Nachman J B; Steinherz P G; Gaynon P S; Uckun F M
Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Leukemia & lymphoma 2000;36(5-6):467-78.
-
2000: Trigg M E; Steinherz P G; Chappell R; Johnstone H S; Gaynon P S; Kersey J H; Cherlow J M; Grossman N J; Sather H N; Hammond G D
Early testicular biopsy in males with acute lymphoblastic leukemia: lack of impact on subsequent event-free survival.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2000;22(1):27-33.
-
1999: Heerema N A; Nachman J B; Sather H N; Sensel M G; Lee M K; Hutchinson R; Lange B J; Steinherz P G; Bostrom B; Gaynon P S; Uckun F
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group.
Blood 1999;94(12):4036-45.
-
1999: Sun L; Goodman P A; Wood C M; Crotty M L; Sensel M; Sather H; Navara C; Nachman J; Steinherz P G; Gaynon P S; Seibel N; Vassilev A; Juran B D; Reaman G H; Uckun F M
Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3753-66.
-
1999: Wiley F M; Ruccione K; Moore I M; McGuire-Cullen P; Fergusson J; Waskerwitz M J; Perin G; Ge J; Sather H N
Parents' perceptions of randomization in pediatric clinical trials. Children Cancer Group.
Cancer practice 1999;7(5):248-56.
-
1999: Heerema N A; Sather H N; Sensel M G; Liu-Mares W; Lange B J; Bostrom B C; Nachman J B; Steinherz P G; Hutchinson R; Gaynon P S; Arthur D C; Uckun F M
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group.
Blood 1999;94(5):1537-44.
-
1999: Sun L; Crotty M L; Sensel M; Sather H; Navara C; Nachman J; Steinherz P G; Gaynon P S; Seibel N; Mao C; Vassilev A; Reaman G H; Uckun F M
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2112-20.
-
1999: Rackoff W R; Ge J; Sather H N; Cooper H A; Hutchinson R J; Lange B J
Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1999;21(4):260-7.
-
1999: Heerema N A; Sather H N; Ge J; Arthur D C; Hilden J M; Trigg M E; Reaman G H
Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(5):679-86.
-
1999: Uckun F M; Nachman J B; Sather H N; Sensel M G; Kraft P; Steinherz P G; Lange B; Hutchinson R; Reaman G H; Gaynon P S; Heerema N A
Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
Leukemia & lymphoma 1999;33(1-2):101-6.
-
1999: Reaman G H; Sposto R; Sensel M G; Lange B J; Feusner J H; Heerema N A; Leonard M; Holmes E J; Sather H N; Pendergrass T W; Johnstone H S; O'Brien R T; Steinherz P G; Zeltzer P M; Gaynon P S; Trigg M E; Uckun F M
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):445-55.
-
1999: Uckun F M; Waurzyniak B J; Sather H N; Sensel M G; Chelstrom L; Nachman J; Gaynon P S; Bostrom B; Ek O; Sarquis M; Steinherz P G; Reaman G H
Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.
Leukemia & lymphoma 1999;32(5-6):475-87.
-
1998: Waurzyniak B J; Heerema N; Sensel M G; Gaynon P S; Kraft P; Sather H N; Chelstrom L; Reaman G H; Uckun F M
Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.
Leukemia & lymphoma 1998;32(1-2):77-87.
-
1998: Balis F M; Holcenberg J S; Poplack D G; Ge J; Sather H N; Murphy R F; Ames M M; Waskerwitz M J; Tubergen D G; Zimm S; Gilchrist G S; Bleyer W A
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
Blood 1998;92(10):3569-77.
-
1998: Uckun F M; Nachman J B; Sather H N; Sensel M G; Kraft P; Steinherz P G; Lange B; Hutchinson R; Reaman G H; Gaynon P S; Heerema N A
Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group.
Cancer 1998;83(9):2030-9.
-
1998: Uckun F M; Sather H N; Waurzyniak B J; Sensel M G; Chelstrom L; Ek O; Sarquis M B; Nachman J; Bostrom B; Reaman G H; Gaynon P S
Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.
Leukemia & lymphoma 1998;30(5-6):503-14.
-
1998: Uckun F M; Herman-Hatten K; Crotty M L; Sensel M G; Sather H N; Tuel-Ahlgren L; Sarquis M B; Bostrom B; Nachman J B; Steinherz P G; Gaynon P S; Heerema N
Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
Blood 1998;92(3):810-21.
-
1998: Nachman J B; Sather H N; Sensel M G; Trigg M E; Cherlow J M; Lukens J N; Wolff L; Uckun F M; Gaynon P S
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
The New England journal of medicine 1998;338(23):1663-71.
-
1998: Heerema N A; Sather H N; Sensel M G; Kraft P; Nachman J B; Steinherz P G; Lange B J; Hutchinson R S; Reaman G H; Trigg M E; Arthur D C; Gaynon P S; Uckun F M
Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1270-8.
-
1998: Harris R E; Sather H N; Feig S A
High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: the Children's Cancer Group experience.
Medical and pediatric oncology 1998;30(4):233-9.
-
1998: Nachman J; Sather H N; Cherlow J M; Sensel M G; Gaynon P S; Lukens J N; Wolff L; Trigg M E
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):920-30.
-
1998: Uckun F M; Sensel M G; Sather H N; Gaynon P S; Arthur D C; Lange B J; Steinherz P G; Kraft P; Hutchinson R; Nachman J B; Reaman G H; Heerema N A
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):527-35.
-
1998: Steinherz P G; Gaynon P S; Breneman J C; Cherlow J M; Grossman N J; Kersey J H; Johnstone H S; Sather H N; Trigg M E; Uckun F M; Bleyer W A
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Cancer 1998;82(3):600-12.
-
1998: Uckun F M; Sensel M G; Sun L; Steinherz P G; Trigg M E; Heerema N A; Sather H N; Reaman G H; Gaynon P S
Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.
Blood 1998;91(3):735-46.
-
1997: Feig S A; Harris R E; Sather H N
Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884).
Medical and pediatric oncology 1997;29(6):534-40.
-
1997: Uckun F M; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Leukemia & lymphoma 1997;27(5-6):445-57.
-
1997: Gaynon P S; Desai A A; Bostrom B C; Hutchinson R J; Lange B J; Nachman J B; Reaman G H; Sather H N; Steinherz P G; Trigg M E; Tubergen D G; Uckun F M
Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review.
Cancer 1997;80(9):1717-26.
-
1997: Uckun F M; Sather H N; Gaynon P S; Arthur D C; Trigg M E; Tubergen D G; Nachman J; Steinherz P G; Sensel M G; Reaman G H
Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 1997;90(1):28-35.
-
1997: Gaynon P S; Crotty M L; Sather H N; Bostrom B C; Nachman J B; Steinherz P G; Heerema N A; Sarquis M; Tuel-Ahlgren L; Uckun F M
Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative.
Leukemia & lymphoma 1997;26(1-2):57-65.
-
1997: Nachman J; Sather H N; Gaynon P S; Lukens J N; Wolff L; Trigg M E
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2222-30.
-
1997: Uckun F M; Gaynon P S; Sensel M G; Nachman J; Trigg M E; Steinherz P G; Hutchinson R; Bostrom B C; Sather H N; Reaman G H
Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2214-21.
-
1997: Uckun F M; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Blood 1997;89(10):3769-77.
-
1997: Uckun F M; Gaynon P; Sather H; Arthur D; Trigg M; Tubergen D; Nachman J; Steinherz P; Sensel M G; Reaman G R
Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 1997;89(7):2488-93.
-
1996: Uckun F M; Reaman G; Steinherez P G; Arthur D C; Sather H; Trigg M; Tubergen D; Gaynon P
Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study.
Leukemia & lymphoma 1996;24(1-2):57-70.
-
1996: Uckun F M; Steinherz P G; Sather H; Trigg M; Arthur D; Tubergen D; Gaynon P; Reaman G
CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 1996;88(11):4288-95.
-
1996: Feig S A; Ames M M; Sather H N; Steinherz L; Reid J M; Trigg M; Pendergrass T W; Warkentin P; Gerber M; Leonard M; Bleyer W A; Harris R E
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.
Medical and pediatric oncology 1996;27(6):505-14.
-
1996: Cherlow J M; Sather H; Steinherz P; Gaynon P; Tubergen D; Trigg M; Novak L; Bleyer W A
Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group.
International journal of radiation oncology, biology, physics 1996;36(1):19-27.
-
1996: Steinherz P G; Gaynon P S; Breneman J C; Cherlow J M; Grossman N J; Kersey J H; Johnstone H S; Sather H N; Trigg M E; Chappell R; Hammond D; Bleyer W A
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):389-98.
-
1996: Smith M; Arthur D; Camitta B; Carroll A J; Crist W; Gaynon P; Gelber R; Heerema N; Korn E L; Link M; Murphy S; Pui C H; Pullen J; Reamon G; Sallan S E; Sather H; Shuster J; Simon R; Trigg M; Tubergen D; Uckun F; Ungerleider R
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):18-24.
-
1995: Uckun F M; Sather H; Reaman G; Shuster J; Land V; Trigg M; Gunther R; Chelstrom L; Bleyer A; Gaynon P
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
Blood 1995;85(4):873-8.
-
1994: Gilchrist G S; Tubergen D G; Sather H N; Coccia P F; O'Brien R T; Waskerwitz M J; Hammond G D
Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2594-600.
-
1994: Shu X O; Reaman G H; Lampkin B; Sather H N; Pendergrass T W; Robison L L
Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Investigators of the Childrens Cancer Group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(8):645-53.
-
1994: Buckley J D; Buckley C M; Ruccione K; Sather H N; Waskerwitz M J; Woods W G; Robison L L
Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(5):856-64.
-
1994: Heerema N A; Arthur D C; Sather H; Albo V; Feusner J; Lange B J; Steinherz P G; Zeltzer P; Hammond D; Reaman G H
Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group.
Blood 1994;83(8):2274-84.
-
1993: Cherlow J M; Steinherz P G; Sather H N; Gaynon P S; Grossman N J; Kersey J H; Johnstone H S; Breneman J C; Trigg M E; Hammond G D
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
International journal of radiation oncology, biology, physics 1993;27(5):1001-9.
-
1993: Nachman J; Sather H N; Buckley J D; Gaynon P S; Steinherz P G; Tubergen D G; Lampkin B C; Hammond G D
Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment.
Cancer 1993;71(10 Suppl):3377-85.
-
1993: Tubergen D G; Gilchrist G S; O'Brien R T; Coccia P F; Sather H N; Waskerwitz M J; Hammond G D
Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):527-37.
-
1993: Tubergen D G; Gilchrist G S; O'Brien R T; Coccia P F; Sather H N; Waskerwitz M J; Hammond G D
Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):520-6.
-
1991: Bleyer W A; Sather H N; Nickerson H J; Coccia P F; Finklestein J Z; Miller D R; Littman P S; Lukens J N; Siegel S E; Hammond G D
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(6):1012-21.
-
1991: Gaynon P S; Steinherz P G; Bleyer W A; Finklestein J Z; Miller D R; Reaman G H; Sather H N; Hammond G D
Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Medical and pediatric oncology 1991;19(4):221-7.
-
1991: Balsom W R; Bleyer W A; Robison L L; Heyn R M; Meadows A T; Sitarz A; Blatt J; Sather H N; Hammond G D
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study.
Medical and pediatric oncology 1991;19(6):486-92.
-
1990: Evans A E; D'Angio G J; Sather H N; de Lorimier A A; Dalton A; Ungerleider R S; Finklestein J Z; Hammond G D
A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):678-88.
-
1990: Nachman J; Palmer N F; Sather H N; Bleyer W A; Coccia P F; Lukens J N; Siegel S E; Hammond G D
Open-wedge testicular biopsy in childhood acute lymphoblastic leukemia after two years of maintenance therapy: diagnostic accuracy and influence on outcome--a report from Children's Cancer Study Group.
Blood 1990;75(5):1051-5.
-
1990: Miller D R; Leikin S L; Albo V C; Palmer N F; Sather H N; Hammond G D
The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):57-66.
-
1990: Gaynon P S; Bleyer W A; Steinherz P G; Finklestein J Z; Littman P; Miller D R; Reaman G; Sather H; Hammond G D
Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Medical and pediatric oncology 1990;18(4):273-9.
-
1989: Miller D R; Coccia P F; Bleyer W A; Lukens J N; Siegel S E; Sather H N; Hammond G D
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1807-15.
-
1989: Buckley J D; Gilchrist G S; Ruccione K; Sather H N; Woods W G; Hammond G D
Multiple sclerosis in mothers of children with acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(10):736-9.
-
1989: Buckley J D; Sather H; Ruccione K; Rogers P C; Haas J E; Henderson B E; Hammond G D
A case-control study of risk factors for hepatoblastoma. A report from the Childrens Cancer Study Group.
Cancer 1989;64(5):1169-76.
-
1988: Maurer H S; Steinherz P G; Gaynon P S; Finklestein J Z; Sather H N; Reaman G H; Bleyer W A; Hammond G D
The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1425-32.
-
1988: Wells R J; Weck P K; Baehner R L; Krivit W; Raney R B; Ortega J A; Bernstein I O; Lampkin B; Whisnant J K; Sather H N
Interferon-alpha n1 in children with recurrent acute lymphocytic leukemia: a phase I study of pharmacokinetics and tolerance.
Journal of interferon research 1988;8(3):309-18.
-
1988: Matsumura M; Atkinson J B; Hays D M; Hammond G D; Siegel S E; Sather H; Grosfeld J; Haase G
An evaluation of the role of surgery in metastatic neuroblastoma.
Journal of pediatric surgery 1988;23(5):448-53.
-
1988: Gaynon P S; Bleyer W A; Steinherz P G; Finklestein J Z; Littman P S; Miller D R; Reaman G H; Sather H N; Hammond G D
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
The American journal of pediatric hematology/oncology 1988;10(1):42-50.
-
1987: Reaman G H; Steinherz P G; Gaynon P S; Bleyer W A; Finklestein J Z; Evans R; Miller D R; Sather H N; Hammond G D
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
Cancer treatment reports 1987;71(11):1033-8.
-
1987: Littman P; Coccia P; Bleyer W A; Lukens J; Siegel S; Miller D; Sather H; Hammond D
Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).
International journal of radiation oncology, biology, physics 1987;13(10):1443-9.
-
1987: Gaynon P S; Baum E S; Samsel C; Sather H
Microcomputer-assisted data management for multiinstitutional pediatric clinical cancer trials.
The American journal of pediatric hematology/oncology 1987;9(1):33-41.
-
1987: Gaynon P S; Steinherz P G; Reaman G H; Bleyer W A; Sather H; Hammond G D
Strategies for the treatment of children with acute lymphoblastic leukemia and unfavorable presenting features.
Haematology and blood transfusion 1987;30():167-72.
-
1987: Hammond G D; Sather H; Bleyer W A; Coccia P
Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia.
Haematology and blood transfusion 1987;30():161-6.
-
1986: Steinherz P G; Gaynon P; Miller D R; Reaman G; Bleyer A; Finklestein J; Evans R G; Meyers P; Steinherz L J; Sather H
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(5):744-52.
-
1986: Mastrangelo R; Poplack D; Bleyer A; Riccardi R; Sather H; D'Angio G
Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment.
Medical and pediatric oncology 1986;14(3):191-4.
-
1986: Bleyer W A; Sather H; Coccia P; Lukens J; Siegel S; Hammond G D
The staging of childhood acute lymphoblastic leukemia: strategies of the Childrens Cancer Study Group and a three-dimensional technic of multivariate analysis.
Medical and pediatric oncology 1986;14(5):271-80.
-
1986: Hammond D; Sather H; Nesbit M; Miller D; Coccia P; Bleyer A; Lukens J; Siegel S
Analysis of prognostic factors in acute lymphoblastic leukemia.
Medical and pediatric oncology 1986;14(3):124-34.
-
1985: Reaman G; Zeltzer P; Bleyer W A; Amendola B; Level C; Sather H; Hammond D
Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(11):1513-21.
-
1984: Littman P; Rosenstock J; Gale G; Krisch R E; Meadows A; Sather H; Coccia P; DeCamargo B
The somnolence syndrome in leukemic children following reduced daily dose fractions of cranial radiation.
International journal of radiation oncology, biology, physics 1984;10(10):1851-3.
-
1984: Robison L L; Nesbit M E; Sather H N; Level C; Shahidi N; Kennedy A; Hammond D
Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group.
The Journal of pediatrics 1984;105(2):235-42.
-
1984: Rogers P C; Bleyer W A; Coccia P; Lukens J N; Siegel S; Sather H; Hammond D
Yield of unpredicted bone-marrow relapse diagnosed by routine marrow aspiration in children with acute lymphoblastic leukaemia. A report from the Children's Cancer Study Group.
Lancet 1984;1(8390):1320-2.
-
1983: Bleyer W A; Coccia P F; Sather H N; Level C; Lukens J; Niebrugge D J; Siegel S; Littman P S; Leikin S L; Miller D R
Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(5):317-25.
-
1983: Sitarz A; Finklestein J; Grosfeld J; Leikin S; Mc Creadie S; Klemperer M; Bernstein I; Sather H; Hammond D
An evaluation of the role of surgery in disseminated neuroblastoma: a report from the Children's Cancer Study Group.
Journal of pediatric surgery 1983;18(2):147-51.
-
1983: Miller D R; Leikin S; Albo V; Sather H; Karon M; Hammond D
Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group.
Cancer 1983;51(6):1041-9.
-
1983: Baum E; Nachman J; Ramsay N; Weetman B; Neerhout R; Littman P; Griffin T; Norris D; Sather H
Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group.
Medical and pediatric oncology 1983;11(1):1-7.
-
1982: Heyn R; Krivit W; Sather H; Hammond D
Evaluation of azapicyl in soft tissue sarcomas in children: a report from the Children's Cancer Study Group.
Cancer treatment reports 1982;66(2):399-401.
-
1982: Nesbit M E; Sather H; Robison L L; Donaldson M; Littman P; Ortega J A; Hammond G D
Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
Cancer research 1982;42(2):674-80.
-
1981: Leikin S; Miller D; Sather H; Albo V; Esber E; Johnson A; Rogentine N; Hammond D
Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens Cancer Study Group.
Blood 1981;58(3):501-8.
-
1981: D'Angio G J; Littman P; Nesbit M; Sather H; Hittle R; Ortega J; Donaldson M; Hammond D
Evaluation of radiation therapy factors in prophylactic central nervous system irradiation for childhood leukemia: a report from the Children's Cancer Study Group.
International journal of radiation oncology, biology, physics 1981;7(8):1031-8.
-
1981: Sather H; Coccia P; Nesbit M; Level C; Hammond D
Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: a report from Childrens Cancer Study Group.
Cancer 1981;48(2):370-6.
-
1981: Miller D R; Leikin S; Albo V; Sather H; Hammond D
Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL).
British journal of haematology 1981;48(2):199-206.
-
1981: Sather H; Miller D; Nesbit M; Heyn R; Hammond D
Differences in prognosis for boys and girls with acute lymphoblastic leukaemia.
Lancet 1981;1(8223):739-43.
-
1981: Nesbit M E; Sather H N; Robison L L; Ortega J; Littman P S; D'Angio G J; Hammond G D
Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group.
Lancet 1981;1(8218):461-6.
-
1981: Miller D R; Leikin S; Albo V; Sather H; Karon M; Hammond D
Intensive therapy and prognostic factors in acute lymphoblastic leukemia of childhood:CCG 141. A report from Childrens Cancer Study Group.
Haematology and blood transfusion 1981;26():77-86.
-
1980: Miller D R; Leikin S; Albo V; Vitale L; Sather H; Coccia P; Nesbit M; Karon M; Hammond D
Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.
Cancer treatment reports 1980;64(2-3):381-92.
Sign-in to see more
